Biotech Co. Hit With Investor Suit Over Alzheimer's Drug Trial
Biotechnology company Cassava Sciences and two of its executives were hit with a proposed class action over allegations that a co-developer of the company's Alzheimer's drug was under investigation by his...To view the full article, register now.
Already a subscriber? Click here to view full article